Home Newsfeeds Apple Analyst Ming-Chi Kuo Tweeted: The Prediction For The Mass Shipment Schedule Is Unchanged, But The Likelihood Of Apple’s 1st-gen AR/MR Headset Release At The Spring Event Is Decreasing. Meanwhile, The Probability Of The Headset Launch Alongside Ip…

Apple Analyst Ming-Chi Kuo Tweeted: The Prediction For The Mass Shipment Schedule Is Unchanged, But The Likelihood Of Apple’s 1st-gen AR/MR Headset Release At The Spring Event Is Decreasing. Meanwhile, The Probability Of The Headset Launch Alongside Ip…

https://twitter.com/mingchikuo/status/1629084937013067777?s=20

byCharles Gross

February 24, 2023

1 minute read

The prediction for the mass shipment schedule is unchanged, but the likelihood of Apple's 1st-gen AR/MR headset release at the spring event is decreasing. Meanwhile, the probability of the headset launch alongside iPhone 15 in 3Q23 is rising. https://t.co/jqd0xtbBUs

— 郭明錤 (Ming-Chi Kuo) (@mingchikuo) February 24, 2023

Trump And Kanye: The Man Who Came To Dinner And Brought A Holocaust Denier Then Asks Host To Be His Running Mate

By Maureen Meehan

November 25, 6:24 PM

Donald Trump hosted white nationalist and antisemite Nick Fuentes at his Mar-a-Lago resort in Palm Beach this week, reported several news outlets. Fuentes, who seems to love the attention he garners by posting racist content including Holocaust denials, came as a guest of fellow antisemite Kanye West, who now goes by Ye.

TSLA

US DOJ Sues Ticketmaster Parent In New Antitrust Suit, Live Nation Responds: ‘It Ignores Everything That Is Actually Responsible’

By Adam Eckert

May 23, 11:51 AM

Live Nation shares traded down in early trading on reports suggesting the DOJ and a group of states were preparing to file an antitrust lawsuit against the entertainment giant. The lawsuit has now officially been filed.

LYV

Raymond James Maintains Strong Buy on Mirum Pharmaceuticals, Raises Price Target to $88

By Benzinga Newsdesk

October 25, 7:24 AM

Raymond James analyst Steven Seedhouse maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Strong Buy and raises the price target from $75 to $88.

MIRM

Toast Announces Leadership Transition; Aman Narang, Co-Founder And COO, To Become CEO Effective January 1, 2024; Current CEO Chris Comparato To Remain On Board Upon Narang’s Appointment

By Happy Mohamed

September 5, 8:31 AM

Aman Narang, Co-Founder and COO, to become CEO effective January 1, 2024 Current CEO Chris Comparato to remain on Board upon Narang's appointment Toast (NYSE:TOST), the all-in-one digital technology platform built

TOST

Apple Analyst Ming-Chi Kuo Tweeted: The Prediction For The Mass Shipment Schedule Is Unchanged, But The Likelihood Of Apple’s 1st-gen AR/MR Headset Release At The Spring Event Is Decreasing. Meanwhile, The Probability Of The Headset Launch Alongside Ip…

Related Posts

Trump And Kanye: The Man Who Came To Dinner And Brought A Holocaust Denier Then Asks Host To Be His Running Mate

US DOJ Sues Ticketmaster Parent In New Antitrust Suit, Live Nation Responds: ‘It Ignores Everything That Is Actually Responsible’

Raymond James Maintains Strong Buy on Mirum Pharmaceuticals, Raises Price Target to $88

Toast Announces Leadership Transition; Aman Narang, Co-Founder And COO, To Become CEO Effective January 1, 2024; Current CEO Chris Comparato To Remain On Board Upon Narang’s Appointment